blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1430026

EP1430026 - 3-DESOXY-VITAMIN D3 ANALOG ESTERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  22.02.2008
Database last updated on 19.10.2024
Most recent event   Tooltip22.02.2008Application deemed to be withdrawnpublished on 26.03.2008  [2008/13]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2004/26]For all designated states
F. HOFFMANN-LA ROCHE AG
124 Grenzacherstrasse
4070 Basel / CH
Inventor(s)01 / USKOKOVIC, Milan, Radoje
253 Highland Avenue
Upper Montclair, NJ 07043 / US
 [2004/26]
Representative(s)Waschbüsch, Klaus
124 Grenzacherstrasse
4070 Basle / CH
[N/P]
Former [2004/26]Waschbüsch, Klaus, Dr.
124 Grenzacherstrasse
4070 Basle / CH
Application number, filing date02777075.912.09.2002
[2004/26]
WO2002EP10233
Priority number, dateUS20010323957P21.09.2001         Original published format: US 323957 P
US20010323870P21.09.2001         Original published format: US 323870 P
[2004/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03027065
Date:03.04.2003
Language:EN
[2003/14]
Type: A1 Application with search report 
No.:EP1430026
Date:23.06.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 03.04.2003 takes the place of the publication of the European patent application.
[2004/26]
Search report(s)International search report - published on:EP03.04.2003
ClassificationIPC:C07C401/00, A61K31/59, A61P3/02, A61P3/14
[2004/26]
CPC:
C07C401/00 (EP,KR); A61P19/08 (EP); A61P19/10 (EP);
A61P3/02 (EP); A61P3/14 (EP); A61P5/18 (EP);
Y02P20/55 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/26]
Extension statesALNot yet paid
LT21.04.2004
LV21.04.2004
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ESTER VON 3-DESOXY-VITAMIN-D3-ANALOGA[2004/26]
English:3-DESOXY-VITAMIN D3 ANALOG ESTERS[2004/26]
French:ESTERS ANALOGUES DE 3-DESOXY-VITAMINE D3[2004/26]
Entry into regional phase21.04.2004National basic fee paid 
21.04.2004Designation fee(s) paid 
21.04.2004Examination fee paid 
Examination procedure15.03.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.04.2004Examination requested  [2004/26]
25.05.2007Despatch of a communication from the examining division (Time limit: M04)
05.06.2007Application deemed to be withdrawn, date of legal effect  [2008/13]
09.11.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/13]
Fees paidRenewal fee
06.09.2004Renewal fee patent year 03
05.09.2005Renewal fee patent year 04
08.09.2006Renewal fee patent year 05
05.09.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9912894  (HOFFMANN LA ROCHE [CH]) [A] 1 * claim 21 * * table I * * examples 2-11 *;
 [A]WO0104089  (HOFFMANN LA ROCHE [CH]) [A] 1 * claims 1-7 * * page 1, lines 15,16 * * page 15, lines 5,6 *;
 [A]EP0808832  (HOFFMANN LA ROCHE [CH]) [A] 1 * claim 22 *
 [DA]  - KOIKE, MICHIAKI ET AL, "20-Cyclopropyl-cholecalciferol vitamin D3 analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines", ANTICANCER RESEARCH, (1999), vol. 19, no. 3A, pages 1689 - 1697, XP009002768 [DA] 1 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.